Novel Situations of Endothelial Injury in Stroke - Mechanisms of Stroke and Strategy of Drug Development: Intracranial Bleeding Associated With the Treatment of Ischemic Stroke: Thrombolytic Treatment of Ischemia-Affected Endothelial Cells With Tissue-Type Plasminogen Activator
Abstract.: Previous studies have shown that the risk of intracranial hemorrhage (ICH) associated with the treatment of ischemic stroke is mainly attributable to antithrombotic agents. On the basis of clinical trials, only tissue-type plasminogen activator (t-PA) has been approved for treating acute...
Saved in:
Main Authors: | Yasuhiro Suzuki (Author), Nobuo Nagai (Author), Kazuo Umemura (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
by: Yasuhiro Suzuki
Published: (2010) -
Novel Situations of Endothelial Injury in Stroke - Mechanisms of Stroke and Strategy of Drug Development: Protective Effects of Antiplatelet Agents Against Stroke
by: Masamitsu Shimazawa, et al.
Published: (2011) -
The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy
by: Wong YS, et al.
Published: (2020) -
Intracranial Arteriopathy and Ischemic Stroke
by: J Gordon Millichap
Published: (2009) -
Difficult questions of intravenous thrombolytic therapy in ischemic stroke
by: Aleksey A. Kulesh
Published: (2021)